SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis (PSNL) is trending following a $1.5 billion all-stock acquisition agreement by Tempus AI (TEM) at $16.25 per share. While the community is actively debating the deal's structure and its potential impact on long-term shareholder value, market sentiment remains divided between those viewing the acquisition as a strategic play for Tempus's oncology platform and others expressing frustration over the valuation and potential impact of the exchange ratio on short-term returns.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market volatility driven by its $1.5 billion all-stock acquisition of Personalis, which has triggered investor concerns regarding dilution, integration risks, and the deal's potential impact on near-term share price performance. While the community is divided, with some investors betting on long-term value in the precision medicine and MRD market, others are actively debating the deal's terms, the impact of high short interest, and the stock's recent bearish technical price action.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is experiencing a sharp surge in price and heavy trading volume following an FDA advisory panel's favorable recommendation to allow the compounding of popular peptides, a move the community views as a major growth catalyst. Investors are actively debating the potential for a significant short squeeze given the stock's high short interest, while some caution against volatile price swings following the regulatory news.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is trending as the market weighs a recent earnings miss against strong fundamental tailwinds, including a record $176 billion backlog and increased guidance fueled by explosive AI data center and grid infrastructure demand. While the stock has faced short-term volatility, the community remains divided between those capitalizing on the dip as a long-term infrastructure play and those concerned by sector-specific headwinds and profit-taking.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending due to a 12-state antitrust lawsuit led by California aimed at blocking its proposed $110 billion merger with Warner Bros. Discovery, a move the community is debating as either a politically motivated shakedown or a significant hurdle to long-term consolidation. While some investors fear the resulting uncertainty and potential financial ticking fees will pressure the stock, others view the current price weakness as a generational buying opportunity, expressing strong confidence that the deal will ultimately proceed.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is seeing intense investor focus as the rare earth sector rallies behind the strengthening narrative of U.S. supply chain independence and the upcoming Jan 1, 2027, deadline for critical mineral compliance. Community members are actively debating the company's potential as a domestic processing leader, with intense discussion surrounding its recent financing, institutional backing, and strategic partnerships, even as some participants express frustration over volatile price swings and accusations of market manipulation.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is gaining significant momentum as investors digest recent progress in its Hydrochemolytic Technology, including pilot plant results and expanding partnerships across waste plastics and crude upgrading verticals. The community is actively discussing the company's technical milestones and potential commercial scaling, with many highlighting its role in the broader circular economy and energy efficiency sectors.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is facing intense scrutiny as investors weigh its long-term performance against broader market benchmarks, with community discourse sharply divided over Cathie Wood's high-conviction growth strategy. While some traders view recent position changes and dip-buying in speculative tech as tactical opportunities, many critics are vocal about the fund's multi-year underperformance and are actively comparing its trajectory to passive index funds.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is attracting significant community attention as investors anticipate imminent global expansion announcements and Q2 earnings, while debates continue over the company's reliance on non-traditional communication channels and potential regulatory headwinds. The stock remains highly sensitive to broader biotech sentiment and heavy short-interest dynamics, with retail sentiment divided between deep conviction in the company's oncology pipeline and frustration over the lack of near-term catalysts.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending as investors bet on the company's pharmaceutical pivot and potential roles in domestic medicine manufacturing following new federal tariff policies. The community is actively discussing the lack of official corporate communication regarding potential contracts while closely monitoring for signs of institutional accumulation and imminent FDA-related catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
